IL17A and psoriasis: The important inflammatory factors of psoriasis (IL‐9, IL‐17) are able to activate platelets, leading to their elevated number, which in turn release more thromboxane and increase blood viscosity, resulting in microcirculation disturbance, while secreting inflammatory mediators, promoting neutrophil aggregation, activation, and thus amplifying the inflammatory response [9].